| Prediction of radiologic outcome-optimized dose plans and post-treatment magnetic resonance images: A proof-of-concept study in breast cancer brain metastases treated with … S Pandey, T Kutuk, MA Abdalah, O Stringfield, H Ravi, MN Mills, ... Physics and Imaging in Radiation Oncology 31, 100602, 2024 | | 2024 |
| Presurgical Upgrade Prediction of DCIS to Invasive Ductal Carcinoma Using Time-dependent Deep Learning Models with DCE MRI JD Mayfield, D Ataya, M Abdalah, O Stringfield, MM Bui, N Raghunand, ... Radiology: Artificial Intelligence, e230348, 2024 | | 2024 |
| A novel MRI-based tumor-targeting theragnostic agent: Magnetoelectric nanoparticles in an in vivo murine KRAS/P53 pancreatic flank tumor model. JM Bryant, E Stimphil, V Andre, V Estrella, K Husain, J Weygand, ... Journal of Clinical Oncology 42 (16_suppl), 3075-3075, 2024 | | 2024 |
| Magnetic resonance imaging of tumor response to stroma-modifying pegvorhyaluronidase alpha (PEGPH20) therapy in early-phase clinical trials AM Arias-Lorza, JR Costello, SR Hingorani, DD Von Hoff, RL Korn, ... Scientific Reports 14 (1), 11570, 2024 | | 2024 |
| Pancreatic Cyst Size Measurement on Magnetic Resonance Imaging Compared to Pathology D Jeong, B Morse, SL Polk, DT Chen, J Li, P Hodul, BA Centeno, ... Cancers 16 (1), 206, 2024 | 1 | 2024 |
| Rules-based Volumetric Segmentation of Multiparametric MRI for Response Assessment in Recurrent High-Grade Glioma H Ravi, SH Hawkins, O Stringfield, M Pereira, DT Chen, H Enderling, ... | 1 | 2023 |
| Tumor response to stroma-modifying therapy: magnetic resonance imaging findings in early-phase clinical trials of pegvorhyaluronidase alpha (PEGPH20) AM Arias-Lorza, JR Costello, SR Hingorani, DD Von Hoff, RL Korn, ... Research Square, 2023 | 1 | 2023 |
| Research briefing P Katiyar, BJ Pichler Nature 7, 969-970, 2023 | 1 | 2023 |
| Oxidative phosphorylation-associated radiomic feature and survival of women with serous ovarian cancer C Colin-Leitzinger, J Perez-Morales, S Eschrich, JK Teer, S Sinha, ... Cancer Research 83 (7_Supplement), 6485-6485, 2023 | | 2023 |
| Pretherapy ferumoxytol-enhanced MRI to predict response to liposomal irinotecan in metastatic breast cancer H Ravi, AM Arias-Lorza, JR Costello, HS Han, DK Jeong, SG Klinz, ... Radiology: Imaging Cancer 5 (2), e220022, 2023 | 7 | 2023 |
| PREDICTING POST-STEREOTACTIC RADIOTHERAPY MAGNETIC RESONANCE IMAGE OUTCOMES OF BREAST CANCER METASTASES TO THE BRAIN S Pandey, T Kutuk, M Mills, M Abdalah, O Stringfield, K Latifi, W Moreno, ... NEURO-ONCOLOGY 24, 161-161, 2022 | | 2022 |
| Quantitative changes in intratumoral habitats on MRI correlate with pathologic response in early-stage ER/PR+ HER2− breast cancer treated with preoperative stereotactic … RJ Weinfurtner, M Abdalah, O Stringfield, D Ataya, A Williams, B Mooney, ... Journal of breast imaging 4 (3), 273, 2022 | 4 | 2022 |
| Quantitative changes in intratumoral habitats on MRI correlate with pathologic response in early-stage ER/PR+ HER2− breast cancer treated with preoperative stereotactic … R Jared Weinfurtner, M Abdalah, O Stringfield, D Ataya, A Williams, ... Journal of Breast Imaging 4 (3), 273-284, 2022 | 1 | 2022 |
| Analysis of MRI radiomic pelvimetry and correlation with margin status after robotic prostatectomy. I Youssef, M Poch, N Raghunand, J Pow-Sang, PAS Johnstone The Canadian Journal of Urology 29 (1), 10976-10978, 2022 | 5 | 2022 |
| MRI response to pre-operative stereotactic ablative body radiotherapy (SABR) in early stage ER/PR+ HER2-breast cancer correlates with surgical pathology tumor bed cellularity RJ Weinfurtner, N Raghunand, O Stringfield, M Abdalah, BL Niell, D Ataya, ... Clinical Breast Cancer 22 (2), e214-e223, 2022 | 13 | 2022 |
| Accelerating Multiparametric MRI for Adaptive Radiotherapy S Pandey University of South Florida, 2022 | | 2022 |
| Radiomic biomarkers to optimize treatment decision and predict patient outcomes in serous ovarian carcinoma J Perez-Morales, CM Colin-Leitzinger, SK Sinha, MJ McGettigan, ... AACR Annual Meeting 2022, 3218, 2022 | | 2022 |
| Pre-treatment adiposity measured by computed tomography and survival of women with high-grade serous ovarian cancer C Colin-Leitzinger, D Jeong, M Abdalah, R Cannioto, JY Chern, E Davis, ... AACR Annual Meeting 2022, 5886, 2022 | | 2022 |
| Predicting Stereotactic Radiosurgery Dose Maps from Pre-Therapy MR Images using a Deep Neural Network S Pandey, T Kutuk, MN Mills, M Abdalah, O Stringfield, K Latifi, ... Proc Intl Soc Mag Reson Med 30, 5403, 2022 | | 2022 |
| R1 and R2* Mismatch on Ferumoxytol-Enhanced MRI Predicts Response of Breast Cancer Brain Metastases to Liposomal Irinotecan H Ravi, AM Arias Lorza, JR Costello, HS Han, DK Jeong, SG Klinz, ... Proc Intl Soc Mag Reson Med 30, 2681, 2022 | 1 | 2022 |
Robert GilliesChair of Cancer Physiology, H. Lee Moffitt Cancer Center在 moffitt.org 的电子邮件经过验证
